Oramed to Present at the CODHy 6th World Congress on Diabetes, Obesity and Hypertension

Oramed LogoJERUSALEM, Feb. 20, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming…

PR NEWSWIRE

About M Fund

SITE ADMIN